| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/23/2005 | CN1190436C Process for preparing granisetron and its salt |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/23/2005 | CN1190433C Phenylpiperazine |
| 02/22/2005 | US6858638 Substituted indazoles, compositions containing them, method of production and use |
| 02/22/2005 | US6858624 Comprises 5,8,14-triazatetracyclo(10.3.1.0.0)-hexadeca-2(11),3,5,7,9-penaene groups; for reducing drug addiction, treating Alzheimer's/Parkinson's diseases, and other nervous system disorders |
| 02/22/2005 | US6858622 Cycloalkano-indole and -azaindole derivatives |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858619 Fused heterocyclic compounds |
| 02/22/2005 | US6858616 Anticoagulant drug |
| 02/22/2005 | US6858599 Tricyclic compound having spiro union |
| 02/17/2005 | WO2005014600A1 Antagonists of mcp-1 function and methods of use thereof |
| 02/17/2005 | WO2005014584A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005014558A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013974A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | WO2005013892A2 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 02/17/2005 | WO2004096982A3 Antibacterial agents |
| 02/17/2005 | WO2004084813A3 Chemical compounds |
| 02/17/2005 | WO2004063330A3 (2-carboxamido) (3-amino) thiophene compounds |
| 02/17/2005 | US20050038249 metal complexes used as prodrugs that may be activated under hypoxic conditions by enzymes or by radiotherapy for treatment of cancer |
| 02/17/2005 | US20050038247 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/17/2005 | US20050038246 PPAR active compounds |
| 02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038067 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic |
| 02/17/2005 | US20050038066 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors |
| 02/17/2005 | US20050038065 Amidation of 1,4-dihydro-1,5-naphthyridine-3-carboxylic acid alkyl ester with a primary amine in presence of a polar solvent by heating; diagnosis and treatment of anxiety, Downs Syndrome, sleep, cognitive and seizure disorders |
| 02/17/2005 | US20050038064 Anticarcinogenic agents; breast, colon, lung, prostate, ovarian, and gastric cancers, leukemia, melanomas; (5R)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione |
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |
| 02/17/2005 | US20050038047 Azaquinazoline derivatives |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038011 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 02/17/2005 | US20050037396 compounds for analyzing primer extension products incorporating universal bases; microsatellite analysis |
| 02/17/2005 | CA2554566A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | CA2535125A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534528A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparationand use as modulators of apoptosis |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2533996A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | CA2529792A1 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 02/17/2005 | CA2529196A1 Benzodiazepine cgrp receptor antagonists |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506779A1 (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina |
| 02/16/2005 | EP1506200A2 Novel diazabicyclic biaryl derivatives |
| 02/16/2005 | EP1506195A2 Non-nucleoside reverse transcriptase inhibitors |
| 02/16/2005 | EP1506194A1 SUBSTITUTED RING-FUSED IMIDAZOLE DERIVATES: GABA sb A /sb RECEPTOR LIGANDS |
| 02/16/2005 | EP1506193A1 Carbamate-substituted pyrazolopyridines |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506189A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof |
| 02/16/2005 | EP1506178A2 Bicyclic modulators of androgen receptor function |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 02/16/2005 | EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1580055A Quinolone carboxylic acid derivatives and their salts |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/15/2005 | US6855730 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/15/2005 | US6855723 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/10/2005 | WO2005012309A1 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| 02/10/2005 | WO2005012301A1 Pyrazoloisoquinoline derivatives as kinase inhibitors |
| 02/10/2005 | WO2005012293A1 Phenylazole compounds, production process, and antioxidants |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012275A2 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012248A1 Benzylamine derivative |
| 02/10/2005 | WO2005011700A1 INHIBITORS OF Akt ACTIVITY |
| 02/10/2005 | WO2005011681A1 Chemical compounds |
| 02/10/2005 | WO2005011648A2 Use of cyclic bioisosteres of purine system derivatives for the treatment diseases caused by disorders of nitrergic and dopaminergic systems |
| 02/10/2005 | WO2005011597A2 Compounds and compositions as protein kinase inhibitors |
| 02/10/2005 | WO2004113362A3 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 02/10/2005 | WO2004113357A3 Nucleoside analog inhibitors of reverse transcriptase |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | WO2004054507A3 Indolizine compounds |
| 02/10/2005 | US20050034108 Processing instructions |
| 02/10/2005 | US20050033064 Intermediates for the production of quinolone carboxylic acid derivatives |
| 02/10/2005 | US20050033040 Self-dispersible bipyridine-based metal complex and ink composition comprising the same |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032837 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders |
| 02/10/2005 | US20050032830 Ether substituted imidazopyridines |
| 02/10/2005 | US20050032829 Process for imidazo[4,5-c]pyridin-4-amines |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032803 as modulators of receptor tyrosine kinases and cytoplasmic tyrosine and serine/threonine kinases; can bind both to active and also to non-active kinases and therefore influence the signal transduction |
| 02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/10/2005 | US20050032779 enzyme inhibitors such as 2-[4-(4-Dimethylaminophenyl)piperazin-1-yl]4,5-dihydroimidazo[4,5,1-ij]quinolin-6-one, used for treating or preventing disorders in which poly/ADP-ribose/ polymerase is involved |
| 02/10/2005 | US20050032777 benzyl carbamates and ureas such as 5-(4-(4-cyclopropylmethylpiperazine-1-carbonylaminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo[5,4-b][1,5]benzodiazepine, used for treatment of sexual disorders |
| 02/10/2005 | US20050032768 pentsaaacycle manganese complexes used as mimetics for oxidoreductase enzymes, for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects |
| 02/10/2005 | US20050032662 Ligand and complex for catalytically bleaching a substrate |
| 02/10/2005 | US20050032650 Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same |